Defining the standard of care: Randomized controlled trials for the treatment of hepatitis C in the HIV-infected person†

This publication has 8 references indexed in Scilit:

• Treatment of chronic hepatitis C in HIV/HCV-coinfection with interferon α-2b+ full-course vs. 16-week delayed ribavirin
  Hepatology, 2004
• Hospitalization Rates Differ by Hepatitis C Status in an Urban HIV Cohort
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
• Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study)
  AIDS, 2003
• Hepatitis C Virus and Human Immunodeficiency Virus Coinfection in an Urban Population: Low Eligibility for Interferon Treatment
  Clinical Infectious Diseases, 2003
• Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
  New England Journal of Medicine, 2002
• Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
  Published by Elsevier ,2001
• Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus Infection
  JAMA, 2000
• Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1998